1cP-LSD: Difference between revisions
Content deleted Content added
Added content was not an accurate reflection of what it says in the paper |
No edit summary |
||
| Line 25: | Line 25: | ||
}} |
}} |
||
'''1cP-LSD''' ('''N1-(cyclopropylmethanoyl)-lysergic acid diethylamide''') is an acylated derivative of [[lysergic acid diethylamide]] (LSD), which has been sold as a [[designer drug]]. In tests on mice it was found to be an active psychedelic with similar potency to [[1P-LSD]].<ref>{{cite journal | vauthors = Brandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, Dowling G, Dempster NM, Wallach J, Passie T, Halberstadt AL | display-authors = 6 | title = Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD) | journal = Drug Testing and Analysis | date = March 2020 | volume = 12 | issue = 6 | pages = 812–826 | pmid = 32180350 | doi = 10.1002/dta.2789 }}</ref> |
'''1cP-LSD''' ('''N1-(cyclopropylmethanoyl)-lysergic acid diethylamide''') is an acylated derivative of [[lysergic acid diethylamide]] (LSD), which has been sold as a [[designer drug]].<ref>Tanaka R, Kawamura M, Hakamatsuka T, Kikura-Hanajiri R. Identification of LSD Derivatives, 1cP-LSD, MIPLA and 1B-LSD in Illegal Products as Paper Sheet. ''Yakugaku Zasshi''. 2020;140(11):1405-1413. {{doi|10.1248/yakushi.20-00124}} {{pmid|33132277}}</ref> In tests on mice it was found to be an active psychedelic with similar potency to [[1P-LSD]].<ref>{{cite journal | vauthors = Brandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, Dowling G, Dempster NM, Wallach J, Passie T, Halberstadt AL | display-authors = 6 | title = Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD) | journal = Drug Testing and Analysis | date = March 2020 | volume = 12 | issue = 6 | pages = 812–826 | pmid = 32180350 | doi = 10.1002/dta.2789 }}</ref> |
||
== Legal status == |
== Legal status == |
||
Revision as of 02:51, 3 January 2021
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C24H29N3O2 |
| Molar mass | 391.515 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
1cP-LSD (N1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug.[1] In tests on mice it was found to be an active psychedelic with similar potency to 1P-LSD.[2]
Legal status
Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on 18 December, 2019.[3]
See also
References
- ^ Tanaka R, Kawamura M, Hakamatsuka T, Kikura-Hanajiri R. Identification of LSD Derivatives, 1cP-LSD, MIPLA and 1B-LSD in Illegal Products as Paper Sheet. Yakugaku Zasshi. 2020;140(11):1405-1413. doi:10.1248/yakushi.20-00124 PMID 33132277
- ^ Brandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, et al. (March 2020). "Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)". Drug Testing and Analysis. 12 (6): 812–826. doi:10.1002/dta.2789. PMID 32180350.
- ^ "Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara" [Twenty-three substances are proposed to be classified as drugs or dangerous goods] (in Swedish). Folkhälsomyndigheten. December 18, 2019.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |